News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
271,812 Results
Type
Article (15236)
Company Profile (282)
Press Release (256294)
Section
Business (80228)
Career Advice (236)
Deals (13318)
Drug Delivery (36)
Drug Development (51146)
Employer Resources (34)
FDA (5922)
Job Trends (5271)
News (146286)
Policy (10291)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (971)
Accelerated approval (2)
Adcomms (12)
Allergies (50)
Alliances (21830)
ALS (61)
Alzheimer's disease (846)
Antibody-drug conjugate (ADC) (88)
Approvals (5939)
Artificial intelligence (109)
Autoimmune disease (13)
Automation (5)
Bankruptcy (104)
Best Places to Work (4682)
BIOSECURE Act (7)
Biosimilars (45)
Biotechnology (232)
Bladder cancer (45)
Brain cancer (19)
Breast cancer (145)
Cancer (1318)
Cardiovascular disease (114)
Career advice (202)
Career pathing (4)
CAR-T (109)
Cell therapy (310)
Cervical cancer (8)
Clinical research (41510)
Collaboration (502)
Compensation (225)
Complete response letters (13)
COVID-19 (1053)
CRISPR (37)
C-suite (146)
Cystic fibrosis (77)
Data (1398)
Denatured (11)
Depression (30)
Diabetes (130)
Diagnostics (1332)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (79)
Drug pricing (29)
Drug shortages (4)
Duchenne muscular dystrophy (82)
Earnings (29980)
Editorial (18)
Employer branding (4)
Employer resources (32)
Events (48634)
Executive appointments (408)
FDA (6554)
Featured Employer (31)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (469)
Gene editing (89)
Generative AI (9)
Gene therapy (233)
GLP-1 (368)
Government (1119)
Grass and pollen (2)
Guidances (19)
Healthcare (6737)
Huntington's disease (21)
IgA nephropathy (22)
Immunology and inflammation (81)
Indications (19)
Infectious disease (1115)
Inflammatory bowel disease (111)
Inflation Reduction Act (8)
Influenza (18)
Intellectual property (58)
Interviews (22)
IPO (7300)
IRA (11)
Job creations (891)
Job search strategy (188)
Kidney cancer (6)
Labor market (4)
Layoffs (209)
Leadership (2)
Legal (1459)
Liver cancer (31)
Lung cancer (187)
Lymphoma (84)
Machine learning (1)
Management (8)
Manufacturing (121)
MASH (49)
Medical device (2680)
Medtech (2681)
Mergers & acquisitions (6311)
Metabolic disorders (372)
Multiple sclerosis (55)
NASH (13)
Neurodegenerative disease (63)
Neuropsychiatric disorders (23)
Neuroscience (1225)
NextGen: Class of 2025 (2078)
Non-profit (893)
Northern California (1567)
Now hiring (21)
Obesity (188)
Opinion (106)
Ovarian cancer (60)
Pain (40)
Pancreatic cancer (51)
Parkinson's disease (108)
Partnered (9)
Patents (113)
Patient recruitment (67)
Peanut (35)
People (25661)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (14514)
Phase II (19175)
Phase III (12367)
Pipeline (744)
Podcasts (47)
Policy (41)
Postmarket research (953)
Preclinical (6112)
Press Release (30)
Prostate cancer (55)
Psychedelics (35)
Radiopharmaceuticals (213)
Rare diseases (281)
Real estate (1438)
Recruiting (14)
Regulatory (8742)
Reports (16)
Research institute (983)
Resumes & cover letters (32)
Rett syndrome (4)
RNA editing (4)
RSV (10)
Schizophrenia (57)
Series A (92)
Series B (60)
Service/supplier (1)
Sickle cell disease (42)
Southern California (1399)
Special edition (11)
Spinal muscular atrophy (119)
Sponsored (11)
Startups (1979)
State (1)
Stomach cancer (4)
Supply chain (19)
The Weekly (35)
United States (12319)
Vaccines (212)
Venture capitalists (28)
Webinars (7)
Weight loss (108)
Women's health (15)
Worklife (3)
Date
Today (80)
Last 7 days (427)
Last 30 days (1678)
Last 365 days (20201)
2025 (4911)
2024 (20758)
2023 (22635)
2022 (27100)
2021 (28125)
2020 (23710)
2019 (16614)
2018 (12056)
2017 (14049)
2016 (12171)
2015 (14694)
2014 (10632)
2013 (7717)
2012 (7781)
2011 (7861)
2010 (7608)
Location
Africa (168)
Alabama (38)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17475)
Australia (2978)
California (3569)
Canada (1064)
China (331)
Colorado (138)
Connecticut (144)
Delaware (88)
Europe (38098)
Florida (420)
Georgia (111)
Idaho (16)
Illinois (215)
India (8)
Indiana (96)
Iowa (1)
Japan (74)
Kansas (59)
Kentucky (6)
Louisiana (3)
Maine (11)
Maryland (448)
Massachusetts (2828)
Michigan (71)
Minnesota (137)
Mississippi (1)
Missouri (24)
Montana (14)
Nebraska (4)
Nevada (15)
New Hampshire (14)
New Jersey (903)
New Mexico (12)
New York (978)
North Carolina (526)
North Dakota (4)
Northern California (1567)
Ohio (108)
Oklahoma (9)
Oregon (21)
Pennsylvania (679)
Puerto Rico (3)
Rhode Island (15)
South America (231)
South Carolina (4)
Southern California (1399)
Tennessee (26)
Texas (411)
Utah (48)
Virginia (72)
Washington D.C. (28)
Washington State (322)
Wisconsin (13)
271,812 Results for "switch therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Molecular Switches Revolutionizing Drug Development & Therapeutic Precision
January 8, 2025
·
1 min read
Biotech Bay
Switch Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
Switch Therapeutics today announced that Dee Datta, Ph.D., co-founder and CEO of Switch Therapeutics, will present and host investor meetings at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference on Thursday, June 27, 2024.
June 25, 2024
·
1 min read
Editorial
FDA Weathers Bait-and-Switch Storm as Staff and Sites Come and Go
Marty Makary, likely FDA commissioner under President Trump, appeared before Congress this week as the agency he’s set to lead continues to be rocked by sweeping changes and about-faces.
March 7, 2025
·
3 min read
·
Jef Akst
Press Releases
Petros Pharmaceuticals to Partner with Renowned Big Data Provider to Enable Rx-to-OTC Switch Across Multiple Indications
March 21, 2025
·
7 min read
Biotech Bay
Switch Therapeutics to Present at Evercore ISI 2024 Emerging Biotech Conference
Switch Therapeutics today announced that Dee Datta, Ph.D., co-founder and CEO of Switch Therapeutics, will participate in a virtual fireside chat at the Evercore ISI 2024 Emerging Biotech Conference on Thursday, February 29, 2024 at 1:05 p.m. ET (10:05 a.m. PT).
February 22, 2024
·
1 min read
Press Releases
ACTG Presents Study at CROI Demonstrating Increased Risk of Obesity and Cardiometabolic Disease After Switch to Integrase Inhibitor-Containing Regimen
March 10, 2025
·
4 min read
Business
Switch Therapeutics Appoints Charles Allerson, Ph.D., as Chief Technology Officer
Switch Therapeutics today announced the appointment of Charles Allerson, Ph.D.
January 3, 2024
·
3 min read
Business
Petros Pharmaceuticals Activates Advisory Committee to Help Guide Rx-to-OTC Switch for STENDRA
Petros Pharmaceuticals, Inc. announces it has formed an Advisory Committee to provide guidance as the company prepares for the potential Rx-to-OTC switch for STENDRA for both development and communication with the U.S. Food and Drug Administration.
May 21, 2024
·
9 min read
Press Releases
Switch Therapeutics Appoints David M. Holtzman, M.D., to Its Scientific Advisory Board and Announces Its First Development Candidate, CASi-APOE, a Liver-Sparing APOE RNAi Therapy
December 3, 2024
·
4 min read
Biotech Bay
Switch Therapeutics to Present at Morgan Stanley 21st Annual Global Healthcare Conference
Switch Therapeutics today announced that Dee Data, Ph.D., Co-Founder and CEO of Switch Therapeutics, will present a corporate overview at the Morgan Stanley 21st Annual Global Healthcare Conference.
September 6, 2023
·
1 min read
1 of 27,182
Next
